ModelEdge

20/20 GeneSystems, Inc.
0001139685
Filing Type8-K
Filing Date4/27/2026
Updated4/28/26, 8:10 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts
EX-4.4GLOBAL AMENDMENT, DATED APRIL 23, 2026, BETWEEN STREETERVILLE CAPITAL, LLC AND 20/20 BIOLABS, INC